Business · 14/12/2010Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for FREESTYLE NAVIGATOR Patent Extension
Summary
The Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the FREESTYLE NAVIGATOR medical device, following a submission to the Director of Patents and Trademarks at the Department of Commerce, requesting patent extension.
Original source language: Federal Register — Health and Human ServicesOpen original release →